Concentrating on Chromatography

How do chemists design molecules that safely carry radioactive metals through the body to target cancer cells?
In this episode of Concentrating on Chromatography, David sits down with Simona Mastroianni and Marianna Tosato to explore the chemistry behind radiopharmaceuticals — drugs that combine radioactive isotopes with specially designed chelators to diagnose and treat cancer.
Their latest research focuses on the theranostic pair lead-203 and lead-212, a powerful combination that enables both imaging and targeted alpha therapy using the same chemical platform. To make this possible, they developed new “molecular cages” that tightly bind lead ions, improving stability, safety, and effectiveness in the body.
Along the way, we break down:
• What radiopharmaceuticals and theranostics actually mean
• Why chelators act like cages for radioactive metals
• How chromatography (HPLC/TLC) verifies radiolabeling and purity
• How NMR shows metals are truly bound
• The path from synthetic chemistry → animal studies → hospitals
• Career advice for undergraduate chemists interested in medical and radiochemistry
If you’ve ever wondered how analytical chemistry, inorganic chemistry, and separation science translate into real cancer treatments, this episode connects the dots.Based on their recent publication demonstrating highly stable, efficiently labeled cyclen-based chelators for 203/212Pb radiopharmaceuticals and the full interview discussion .🎧
Perfect for students in:Analytical chemistry • Chromatography • Inorganic chemistry • Radiochemistry • Pharmaceutical sciences

radiopharmaceuticals, lead-212 therapy, theranostics, chelators, chromatography, HPLC, NMR, radiochemistry, cancer drug development, analytical chemistry careers

Neglected and opportunistic infectious diseases affect some of the world’s most vulnerable populations—but often receive the least attention from traditional drug discovery pipelines.In this episode of Concentrating on Chromatography, host David Oliva sits down with Brad Haubrich to explore how early-stage drug discovery is being applied to fungal and parasitic pathogens, including those responsible for neglected tropical diseases and infections that disproportionately affect immunocompromised patients.Brad shares how his lab approaches drug discovery when the pathogen is eukaryotic—and therefore biologically similar to humans—making selectivity one of the biggest challenges. The conversation covers:* What defines neglected and opportunistic diseases—and why commercial incentives often fall short* Target-based vs. phenotypic drug discovery and when each approach makes sense* Using binding kinetics and residence time to improve selectivity and reduce off-target effects* Where chromatography, metabolomics, and mass spectrometry still play a critical role—even when not front-and-center* The growing (and realistic) role of AI in drug discovery, especially for underfunded disease areas* Why World Neglected Tropical Diseases Day (January 30) matters for raising awareness and accelerating progressThis episode highlights how analytical chemistry, separation science, and biological insight intersect in the earliest stages of drug discovery—and why progress in this space depends as much on collaboration and curiosity as it does on technology.🎙️ **Recorded in recognition of World Neglected Tropical Diseases Day**

Haloacetic acids (HAAs) are disinfection byproducts formed when chlorine or bromine reacts with organic matter in water—and some are linked to serious health concerns. In this episode of Concentrating on Chromatography, we sit down with Jessica Whitehouse, MSc student at the University of Calgary, to discuss how she developed a GC-MS method to detect and quantify HAAs in real-world water samples.During her undergraduate research at Thompson Rivers University, Jessica tackled a major challenge faced by many academic labs: how to analyze regulated environmental contaminants without access to GC-ECD instrumentation. Using dispersive liquid–liquid microextraction, derivatization, and GC-MS, she built a faster, more accessible workflow—and applied it to tap water, swimming pools, and hot tubs.In this conversation, we cover:* What haloacetic acids are and why they matter* Why standard EPA methods can be difficult for smaller or teaching-focused labs* How GC-MS can be adapted for HAA analysis* The challenges of derivatization and temperature program optimization* Unexpected findings in brominated vs. chlorinated HAAs* Why pool and hot tub water can show surprisingly high HAA levels* The excitement (and frustration) of first-time method development* Advice for undergraduate and early-career analytical chemistsJessica also shares how this project led directly to her current MSc research on ozone and nanobubble water disinfection, where she’s now expanding into ion chromatography.Whether you work in **environmental analysis, chromatography, GC-MS, or are just starting your journey in analytical chemistry**, this episode offers practical insight into real lab constraints, method development, and the joy of finding your first analyte peak.🔬 Topics: GC-MS, haloacetic acids, water analysis, method development, derivatization, environmental chemistry🎓 Audience: Academic researchers, students, environmental labs, analytical chemists

In this episode of Concentrating on Chromatography, host David Oliva sits down with Dr. Steven Weinman, Associate Professor of Chemical and Biological Engineering at the University of Alabama, to explore how membrane science and chromatography intersect in modern separation challenges.Steven shares his journey from chemical engineering student to membrane researcher, and explains how membranes are used not only for water purification, but also for sample preparation, pre-treatment, and concentration in analytical workflows. The conversation dives deep into PFAS removal, nanofiltration vs. reverse osmosis, and how chromatography and mass spectrometry are essential for validating membrane performance.Key topics discussed include:* How membranes function as separation and concentration tools* Nanofiltration vs. reverse osmosis for salts and PFAS* The role of chromatography (LC-MS, GC-MS, ion chromatography) in verifying contaminant removal* Challenges in scaling academic separation technologies to industry* Sustainability in membrane manufacturing and PFAS-related regulations* Training students to balance fundamental science with real-world applicationsWhether you work in environmental analysis, chromatography, mass spectrometry, water quality, or separation science, this episode provides valuable insight into how different separation technologies complement each other—and where the field is heading next.🎧 Subscribe for more conversations on chromatography, sample preparation, and analytical science.

How do the hidden carbohydrate structures on your favorite protein powders shape the gut microbiome? In this episode of Concentrating on Chromatography, Matthew Bolino, M.S., from the University of Nevada, Reno, breaks down his latest research on N‑glycans from common dietary proteins (whey, egg white, soy, and pea) and how their structural diversity influences microbial fermentation and short‑chain fatty acid production.Bolino explains what N‑glycans are, why they behave like fiber in the gut, and how his team isolates and characterizes them using ethanol washes, enzymatic release (PNGase F and gut‑derived endoglycosidases), and advanced MALDI‑TOF and HILIC‑QTOF workflows. He also discusses his 2025 work comparing synthetic versus bovine whey N‑glycomes and mapping N‑glycan profiles across dietary protein sources, revealing how glycan architecture can reshape community diversity in in vitro fecal fermentations.Geared toward undergraduate and early‑career analytical chemists, this conversation dives into practical mass spec trade‑offs (MALDI vs QTOF vs LC/GC), real‑world troubleshooting in glycomics labs, and how microbiome‑targeted therapeutics and “symbiotic” designs may emerge from pairing specific microbes with preferred glycan structures. Bolino closes with career advice on building biomolecular analysis skills, understanding instrumentation fundamentals, and entering the rapidly growing field of glycomics and microbiome research.